GeNO articles & resources on Made-in-China.com

Walmart Driver Delivers a Win at National Championships

Oct 13, 2016

He practices nearly every day, honing his skills and aiming to be the best in his field. He’s won numerous competitions, most recently being crowned a national grand champion. But he’s not an athlete; he’s a truck ...

Tags: Mike White, Walmart driver, National Truck Driving Championships

Pfizer Is Planning for Internal Classification of Its Commercial Operations

Jul 31, 2013

Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients. The three business ...

Tags: Pfizer, Commercial Businesses

Tofacitinib Has Obtained Approval in Several Additional Countries Globally

Jul 17, 2013

Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...

Tags: Arthritis Drug, International Approvals

Pfizer Has Collaborated with Humedica to Promote Capabilities to Receive Real World Data

Dec 25, 2012

Pfizer and Humedica have formed a multi-year strategic partnership to jointly advance capabilities to receive insights from real world data. As part of the alliance, the companies will conduct data-driven collaborative research to ...

Tags: Humedica, Pfizer Collaborate, Data Driven

GeNO Obtains a Clearance for Its Inhaled NO Delivery System, GeNOsyl MV-1000, From FDA

Dec 14, 2012

GeNO has obtained a clearance for its inhaled nitric oxide (NO) delivery system, GeNOsyl MV-1000, from the US Food and Drug Administration (FDA). GeNOsyl MV-1000 system, which incorporates a primary delivery system, a backup system, ...

Tags: FDA, inhaled nitric oxide delivery system, clinical product, GeNO

GeNO Receivs Four US Patents for NO Generation Chemistry and Delivery Technology

Dec 14, 2012

GeNO has received four additional US patents for its proprietary nitric oxide (NO) generation chemistry and delivery technology. The patent No. 8,211,368 describes the conversion of nitrogen dioxide (NO2) to NO where NO2 is stored as ...

Tags: US patent, clinical technology, clinical research, GeNO

GeNO Received Four Additional US Patents

Dec 5, 2012

Inhaled nitric oxide drug products developer GeNO has received four additional US patents on its proprietary inhaled nitric oxide (NO) generation chemistry and delivery technology, bringing the total number of US patents to sixteen. The ...

Tags: inhaled nitric oxide drug, NO, NO2, GeNO

Pfizer Has Won US FDA Approval

Dec 5, 2012

Pfizer has won US FDA approval for its rheumatoid arthritis (RA) therapy, Xeljanz (tofacitinib citrate) 5mg twice daily, indicated for patients who failed to respond to methotrexate. Xeljanz can be used as a single treatment regime or as ...

Tags: Pfizer, tofacitinib citrate, Xeljanz

GeNo Has Received Us Patents for Its Proprietary No Generation and Delivery Technology

Nov 27, 2012

GeNO has received two new US patents for its proprietary nitric oxide(NO)generation and delivery technology. The US patent no.8,173,072 describes the conversion of nitrogen dioxide(NO2)to nitric oxide(NO),using the GeNO cartridge ...

Tags: nitric oxide(NO)generation, nitric oxide(NO)delivery, US Patents, GeNO

FDA Has Accepted Geno's Filing of NDA for MVG

Nov 27, 2012

The US Food and Drug Administration (FDA) has accepted GeNO's filing of new drug application (NDA) for GeNOsyl MVG-2000 nitric oxide delivery system. GeNOsyl nitric oxide is a vasodilator which is indicated for the treatment of term and ...

Tags: GeNOsyl nitric oxide, FDA

Orphan Drug Designation Was Granted Based on a Plausible Hypothesis

Aug 15, 2012

The US Food and Drug Administration (FDA) has granted orphan drug designation to GeNO for use of inhaled nitric oxide (NO) in treatment of persistant pulmonary hypertension of the newborn (PPHN). The orphan drug designation was granted ...

Tags: orphan drug designation, FDA, persistant pulmonary hypertension

GeNO

Related Products